Errors in the Abstract, Results, and Table 2
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMeta-analysis and systematic reviews · Hemodynamic Monitoring and Therapy · Advanced Causal Inference Techniques
In the Original Investigation titled, “Pharmacist-Led Management Model and Medication Adherence Among Patients With Chronic Heart Failure: A Randomized Clinical Trial,”^1^ published online December 20, 2024, there were errors in the odds ratios reported in the Abstract, Results, and Table 2. In the Abstract, the final sentence of the Results should be the following: “At 52 weeks, the intervention group had a significantly higher PDC for heart failure medication (8.1%; 95% CI, 5.5%-10.7%; P < .001) and a greater proportion of patients with PDC of 80% or greater (odds ratio, 2.94; 95% CI, 1.85-4.67; P < .001) compared with the control group.” In the second paragraph of the Results section in the text, the fifth sentence should be the following: “The proportion of patients with a PDC of 80% or greater among patients with CHF was significant (odds ratio, 2.94; 95% CI, 1.85-4.67; P < .001).” In Table 2, the odds ratios were incorrect. This article has been corrected.
The reference list from the paper itself. Each links out to its DOI / PubMed record.